Ceramide binds to the CaLB domain of cytosolic phospholipase A 2 and facilitates its membrane docking and arachidonic acid release
The DOI matches its Crossref record.
Abstract
Excessive production of eicosanoids is characteristic of many inflammatory diseases. In this study we show that ceramide, which is an early messenger of inflammatory cytokine action, exerts a dual effect on the cytosolic phospholipase A 2 (cPLA 2 ), the rate‐limiting enzyme in arachidonic acid release and subsequent eicosanoid formation. Stimulation of renal mesangial cells with exogenous short‐chain ceramide analogs for 30 and 60 min leads to a concentration‐dependent increase in arachidonic acid release that is not blocked by specific inhibitors of mitogen‐activated protein kinase pathways. This suggests that these established upstream activators of cPLA 2 are not involved in ceramide‐induced arachidonic acid release. By use of photoactivatable ceramide analogs, D‐ and L‐ [ 125 I]3‐trifluoromethyl‐3‐( m ‐iodophenyl)diazirineceramides (TID‐ceramides), we observed a direct interaction of ceramide with cPLA 2 . This interaction was independent of the absolute configuration as D‐ and L‐TID‐ceramide were equally effective in binding to cPLA 2 . Moreover, recombinant CaLB domain of cPLA 2 as well as a mutant deficient in the connecting ‘hinge’ domain of cPLA 2 , efficiently bound D‐ and L‐TID‐ceramides, whereas the catalytic domain did not interact with TID‐ceramides. In vitro binding assays reveal that stearoyl‐arachidonyl‐phosphatidylcholine (SAPC)‐liposomes containing increasing mol% of ceramide lead to an increased association of recombinant cPLA 2 to the liposomes. Furthermore, measurement of cPLA 2 activity in vitro shows that the presence of SAPC‐liposomes resulted in only weak cPLA 2 activity. However, the activity dramatically increases by addition of ceramide to the liposomes. Furthermore, liposomes containing SAPC and sphingomyelin resulted in no better substrate than SAPC liposomes, unless bacterial sphingomyelinase was added to generate ceramide, which then causes a marked increase in cPLA 2 activity. These results demonstrate that ceramide can interact directly with cPLA 2 via the CaLB domain and thereby serves as a membrane‐docking device that facilitates cPLA 2 action in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kudo, I., & Murakami, M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00020-5 · Cited by 757
Radiation and ceramide-induced apoptosis
Kolesnick, R., & Fuks, Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206702 · Cited by 506
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16127 · Cited by 393
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216127 · Cited by 351
The metabolism and function of sphingolipids and glycosphingolipids
Lahiri, S., & Futerman, A. H. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7076-0 · Cited by 344
Metadata
- Authors
- Huwiler, A., Johansen, B., Skarstad, A., & Pfeilschifter, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-11-09
- Volume
- 15
- Issue
- 1
- Pages
- 7-9
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1998702692
- Cited by
- 131
- References
- 0
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ceramide binds to the CaLB domain of cytosolic phospholipase A 2 and facilitates its membrane docking and arachidonic acid release. https://app.cochat.ai/papers/10.1096/fj.00-0370fje
- The paper
- Huwiler, A., Johansen, B., Skarstad, A., & Pfeilschifter, J. (2001). Ceramide binds to the CaLB domain of cytosolic phospholipase A 2 and facilitates its membrane docking and arachidonic acid release. The FASEB Journal. https://doi.org/10.1096/fj.00-0370fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.